Page 37 - Cronos Group News Today

Cronos Group (NASDAQ:CRON – Get Rating) and Jushi (OTCMKTS:JUSHF – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Institutional and Insider Ownership 11.9% of Cronos Group shares are […]

Cronos Group Inc. (TSE:CRON – Get Rating)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as C$2.53 and last traded at C$2.53, with a volume of 75825 shares changing hands. The stock had previously closed at C$2.65. Analyst Upgrades and Downgrades Several equities analysts recently commented […]

Investors are too pessimistic about the future of the tobacco industry in the United States.

The win streak continued Thursday for stock markets in Canada’s largest centre, as gains in utilities and consumer stocks led the way towards the 20-thousand-point mark. The TSX closed the day up 141.43 points at 19,940.99. The Canadian dollar ...

Cronos Group Inc. (NASDAQ:CRON – Get Rating) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 8,450,000 shares, a growth of 18.0% from the February 28th total of 7,160,000 shares. Based on an average daily trading volume, of 1,730,000 shares, the short-interest ratio […]

Cronos Group Inc. (NASDAQ:CRON – Get Rating) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 8,450,000 shares, an increase of 18.0% from the February 28th total of 7,160,000 shares. Based on an average daily volume of 1,730,000 shares, the short-interest ratio is […]

Should You Buy or Sell Cronos Group Stock? Get The Latest CRON Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

The main TSX index remains on track to end the first quarter of 2023 in positive territory.

Altria has more than a decade of annual dividend increases. But there should be some concerns about the future given recent missteps.

Following its failed investment in Juul, Altria is exploring other smoke-free industries.